Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system.
The hypothesis that the capability of agents to mobilize arachidonic acid (AA) could predict increased anandamide (ANA) synthesis in a macrophage cell line has been examined. Lipopolysaccharide (LPS), platelet-activating factor (PAF) and cannabinoids such as Delta9-tetrahydrocannabinol (THC) and anandamide were all found to be agonists for the release of AA and led to increased ANA synthesis in RAW264.7 mouse macrophage cells. Nitric oxide, in contrast, stimulated AA release without raising ANA levels. ANA stimulation of its own synthesis indicates the existence of a positive feedback mechanism. The possible involvement of the CB2 receptor in THC-mediated AA release and ANA synthesis is addressed using the antagonist SR144528. ANA synthesis is also increased by the combination of calcium ionophore and indomethacin, suggesting that ANA is metabolized by a cyclooxygenase in this system. The data imply that ANA could play a role in the response of the immune system to cannabinoids and bacterial endotoxins and that AA mobilization is a predictor for increased ANA synthesis.
Pestonjamasp
V K
VK
Department of Biochemistry and Molecular Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Burstein
S H
SH
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D001095:Arachidonic Acids / Q000032:analysis / Q000096:biosynthesis* / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002460:Cell Line; D013759:Dronabinol / Q000494:pharmacology; D063388:Endocannabinoids; D007107:Immune System / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D007476:Ionophores / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D010972:Platelet Activating Factor / Q000494:pharmacology; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000502:physiology
D001095:Arachidonic Acids; D063388:Endocannabinoids; D007476:Ionophores; D008070:Lipopolysaccharides; D010972:Platelet Activating Factor; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D016718:Arachidonic Acid; D000001:Calcimycin; D013759:Dronabinol; C078814:anandamide; D007213:Indomethacin